Publications Database

Anagnostou E. et al. (2006)

Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder.

Journal of Clinical Psychopharmacology

26(4), pp. 444-446

Awad G. A. (1996)

The use of selective serotonin reuptake inhibitors in young children with pervasive developmental disorders: some clinical observations.

Canadian Journal of Psychiatry

August, 41(6), pp. 361-366

Read Abstract (New Window)

Buchsbaum M. (2001)

Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study

International Journal of Neuropsycholpharmacology

4(2), pp. 119-125

Read Abstract (New Window)

Consoli A. et al. (2010)

Lorazepam, fluoxetine and packing therapy in an adolescent with pervasive developmental disorder and catatonia.

Journal of Physiology Paris

104(6), pp. 309-314.

Read Abstract (New Window)

Coury D. (2011)

Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders.

Evidence Based Mental Health

May, 127(5),

Read Abstract (New Window) Read Full (New Window)

DeLong G. R. , Teague L. , McSwain K. M. (1998)

Effects of fluoxetine treatment in young children with idiopathic autism

Developmental Medicine and Child Neurology

40(8), pp. 551-562

Read Abstract (New Window)

Dove D. et al. (2012)

Medications for adolescents and young adults with autism spectrum disorders: A systematic review.

Pediatrics

130(4), pp. 717 -726.

Read Abstract (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Dialogues in Clinical Neuroscience

14(3), pp. 263-279.

Read Abstract (New Window) Read Full (New Window)

Fatemi S. H. (1998)

Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial

Journal of Autism and Developmental Disorders

28(4), pp. 303-307

Read Abstract (New Window)

Hazell P. (2007)

Drug therapy for attention-deficit hyperactivity disorder-like symptoms in autistic disorder.

Journal of Paediatrics and Child Health

43(1), pp. 19-24

Read Abstract (New Window)

Hirota T. et al. (2014)

Antiepileptic medications in autism spectrum disorder: A systematic review and meta-analysis.

Journal of Autism and Developmental Disorders

44(4), pp. 948-957.

Read Abstract (New Window)

Hollander E. et al. (2012)

A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.

American Journal of Psychiatry

169(3), pp. 292-299.

Read Abstract (New Window)

Huang S. , Tsai S. , Yang H. (2010)

Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder.

Chang Gung Medical Journal

33(2), pp. 211-215

Read Abstract (New Window) Read Full (New Window)

Kolevzon A. , Mathewson K. , Hollander E. (2006)

Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.

Journal of Clinical Psychiatry

67(3), pp. 407-414

Read Abstract (New Window)

Masi G. (2004)

Pharmacotherapy of pervasive developmental disorders in children and adolescents.

CNS Drugs

18(14), pp. 1031-1052

Read Abstract (New Window)

McPheeters M. L. et al. (2011)

A systematic review of medical treatments for children with autism spectrum disorders.

Pediatrics

127(5), e1312-e1321

Read Abstract (New Window) Read Full (New Window)

Mohiuddin S. , Ghaziuddin M. (2013)

Psychopharmacology of autism spectrum disorders: A selective review.

Autism

17(6), pp. 645-654.

Read Abstract (New Window)

Moore M. L. , Eichner S. F. , Jones J. R. (2004)

Treating functional impairment of autism with selective serotonin-reuptake inhibitors.

Annals of Pharmacotherapy

38(9), pp. 1515-1519

Read Abstract (New Window)

American Society of Health-System Pharmacists (2008)

Fluoxetine.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Scahill L. , Koenig K. (1999)

Pharmacotherapy in children and adolescents with pervasive developmental disorders.

Journal of Child and Adolescent Psychiatric Nursing

12(1), pp. 41-43

Read Abstract (New Window)